Fundraising Fox

Lirio

Knoxville, US · Founded 2016 · Delaware corporation

Lirio offers a patient engagement platform that combines behavioral science and agentic AI to deliver personalized "Precision Nudging" outreach that helps patients and members overcome barriers and take health actions. It serves health systems, health plans, life sciences organizations, and retail pharmacies to close care gaps, improve medication adherence, and increase vaccine and clinic utilization.

AI & Machine LearningDigital HealthHealthtech

Founders & leadership

GH
George Hashbarger, Jr.Executive
MD
Marten den HaringCEO
JF
Jeremy FloydCEO and President
CS
Craig S. DavisExecutive
PHPatrick Hunt
Patrick HuntExecutive
DB
Doug BoalsExecutive
ABAmy Bucher
Amy BucherChief Behavior Officer

Board

MR
Michael R. WestBoard director
WE
William E. MayerBoard director
KO
Kevin O'BrienBoard director
JD
J. Douglas HolladayBoard director

Reported raises · per SEC filings

Form D private placements

$78.2M disclosed across 16 rounds · 2016–2026

▶$1.6MraisedMay 2026 · 10 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Swati ReichmuthExecutive Officer
  • Kevin O'BrienDirector
  • Marten den HaringExecutive Officer, Director
  • William E. MayerDirector
  • Michael R WestExecutive Officer, Director
Offering amount
$20M
Amount sold
$1.6M
First sale
Apr 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.4MraisedJul 2024 · 71 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • George Hashbarger, Jr.Executive Officer
  • Michael R. WestDirector
  • Marten den HaringExecutive Officer, Director
  • William E. MayerDirector
  • Kevin O'BrienDirector
Offering amount
$33M
Amount sold
$17.4M
Finders' fees
$44.5K
Proceeds to insiders
$847.8K
Placement agents
Orka Capital Ltd
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.6MraisedSep 2023 · 54 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin O'BrienDirector
  • Michael R. WestExecutive Officer, Director
  • George Hashbarger, Jr.Executive Officer
  • Marten den HaringExecutive Officer, Director
  • William E. MayerDirector
Offering amount
$27M
Amount sold
$11.6M
Proceeds to insiders
$2M
First sale
Aug 2023
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedJul 2022 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • George Hashbarger, Jr.Executive Officer
  • William E. MayerDirector
  • Marten den HaringExecutive Officer, Director
  • Michael R. WestExecutive Officer, Director
  • Kevin O'BrienDirector
Amount sold
$3M
First sale
Jul 2022
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.4MraisedMay 2022 · 49 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin O'BrienDirector
  • Marten den HaringExecutive Officer, Director
  • George Hashbarger, Jr.Executive Officer
  • William E. MayerDirector
  • Michael R. WestExecutive Officer, Director
Offering amount
$27.5M
Amount sold
$14.4M
First sale
Apr 2022
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedMar 2022 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • George Hashbarger, Jr.Executive Officer
  • William E. MayerDirector
  • Douglas D. HawthorneDirector
  • Marten den HaringExecutive Officer, Director
  • Kevin O'BrienDirector
  • John M. Starcher, Jr.Director
  • Michael R. WestExecutive Officer, Director
  • Mark PacalaDirector
Offering amount
$3M
Amount sold
$1.5M
First sale
Feb 2022
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.4MraisedNov 2021 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin O'BrienDirector
  • Mark PacalaDirector
  • Marten den HaringExecutive Officer, Director
  • John M. Starcher, Jr.Director
  • William E. MayerDirector
  • Douglas D. HawthorneDirector
  • Michael R. WestExecutive Officer, Director
  • George Hashbarger, Jr.Executive Officer
Offering amount
$3M
Amount sold
$1.4M
First sale
Oct 2021
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$853KraisedJun 2021 · 11 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark PacalaDirector
  • Michael R. WestExecutive Officer, Director
  • William E. MayerDirector
  • Marten den HaringExecutive Officer
  • John M. Starcher, Jr.Director
  • George Hashbarger, Jr.Executive Officer
  • Kevin O'BrienDirector
  • Douglas D. HawthorneDirector
Offering amount
$5M
Amount sold
$853K
First sale
Jun 2021
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Fiveable38 shared keywordsFiveable provides AI-powered exam preparation for AP classes, offering practice questions with automated scoring and personalized study tools for high school students.

Companies competing with Lirio for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Lirio Debuts Behavioral-Science Backed Patient Engagement Solution for Life Sciences Organizationsbusinesswire.com · Oct 2025Evernow Raises $28.5M in Series A Fundingfinsmes.com · Apr 2022Lirio Announces Series A Funding Roundlirio.com · Feb 2019

Frequently asked questions

What does Lirio do?
Lirio offers a patient engagement platform that combines behavioral science and agentic AI to deliver personalized "Precision Nudging" outreach that helps patients and members overcome barriers and take health actions. It serves health systems, health plans, life sciences organizations, and retail pharmacies to close care gaps, improve medication adherence, and increase vaccine and clinic utilization.
How much funding has Lirio raised?
Lirio has disclosed $78.2M raised across 16 rounds.
Where is Lirio headquartered?
Lirio is headquartered in Knoxville, US.